Is this your app? Claim this page to add your own description, links and contact info. It's free. →

IOTA ADNEX

IOTA ADNEX at Mac App Store analyse

Katholieke Universiteit te Leuven
Medical
9,536 ratings · Power index: 205
Free Mac App Store Follow Website
Version 1.0.5
Size 3.48 Mb
Updated 8 years ago
Released 28 Oct 2014

How do you feel about this app?

Screenshots

Description

The ADNEX risk model can be used by medical doctors to preoperatively estimate the likelihood that an ovarian (including para-ovarian and tubal) tumor is benign, borderline, a stage I cancer, stage II-IV cancer, or secondary metastatic cancer (i.e. metastasis of non-adnexal cancer to the ovary). The model is based on data derived from women found to have at least one adnexal tumor that was judged not to be physiological, underwent a standardized ultrasound examination, and was later selected for surgery. The ADNEX model contains nine predictors: age, serum CA-125 (U/ml), type of center (oncology vs other), maximum lesion diameter, proportion of solid tissue, number of papillary projections, the presence of >10 cyst locules, acoustic shadows, and ascites. An oncology center is defined as a tertiary referral center with a specific gynecological oncological unit. The model was developed by clinicians and statisticians from the International Ovarian Tumour Analysis (IOTA) group, and is based on clinical and ultrasound data from almost 6000 women recruited at 24 centers in 10 countries (Italy, Belgium, Sweden, Czech Republic, Poland, France, UK, China, Spain, and Canada). A full description of model development and validation is given in Van Calster B, Van Hoorde K, Valentin L, Testa AC, Fischerova D, Van Holsbeke C, Savelli L, Franchi D, Epstein E, Kaijser J, Van Belle V, Czekierdowski A, Guerriero S, Fruscio R, Lanzani C, Scala F, Bourne T, Timmerman D. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. The BMJ 2014;349:g5920.

Estimates

Monthly Downloads > 4.51k
Est. Revenue ~ $1.85k
Share on X

Search Keywords 2

# Term Country Place Priority
1 iota adnex #1
2 iota #20

Availability

Devices

iPhone3GS iPadWifi iPad3G iPhone4 iPodTouchThirdGen iPodTouchFourthGen iPad2Wifi iPad23G iPhone4S iPadThirdGen iPadThirdGen4G iPhone5 iPodTouchFifthGen iPadFourthGen iPadFourthGen4G iPadMini iPadMini4G iPhone5c iPhone5s iPadAir iPadAirCellular iPadMiniRetina iPadMiniRetinaCellular iPhone6 iPhone6Plus iPadAir2 iPadAir2Cellular iPadMini3 iPadMini3Cellular iPodTouchSixthGen iPhone6s iPhone6sPlus iPadMini4 iPadMini4Cellular iPadPro iPadProCellular iPadPro97 iPadPro97Cellular iPhoneSE iPhone7 iPhone7Plus iPad611 iPad612 iPad71 iPad72 iPad73 iPad74 iPhone8 iPhone8Plus iPhoneX iPad75 iPad76 iPhoneXS iPhoneXSMax iPhoneXR iPad812 iPad834 iPad856 iPad878 Watch4 iPadMini5 iPadMini5Cellular iPadAir3 iPadAir3Cellular iPodTouchSeventhGen iPhone11 iPhone11Pro Watch5 iPadSeventhGen iPadSeventhGenCellular iPhone11ProMax iPhoneSESecondGen iPadProSecondGen iPadProSecondGenCellular iPadProFourthGen iPadProFourthGenCellular

Pricing by country

Country Price
Canada 24.99 CAD
China 148 CNY
France 22.99 EUR
Germany 22.99 EUR
Italy 22.99 EUR
Netherlands 22.99 EUR
Portugal 22.99 EUR
Spain 22.99 EUR
Poland 21.99 EUR
UK 19.99 GBP
India 1999 INR
Japan 3000 JPY
Korea, Republic Of 29000 KRW
Poland 99.99 PLN
Russia 1790 RUB
Turkey 599.99 TRY
USA 19.99 USD
Korea, Republic Of 21.99 USD
Ukraine 22.99 USD